Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins  by Dubois, Bénédicte et al.
Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins
BeŁneŁdicte Duboisa, Willy J. Peumansb, Els J.M. Van Dammeb, Jo Van Dammea,
Ghislain Opdenakkera;*
aRega Institute for Medical Research, Laboratory of Molecular Immunology, University of Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium
bLaboratory for Phytopathology and Plant Protection, University of Leuven, Willem de Croylaan 42, 3001 Leuven, Belgium
Received 21 March 1998
Abstract The stimulatory or inhibitory effects of plant lectins
on the production of gelatinase A (MMP-2) and gelatinase B
(MMP-9) by mononuclear white blood cells was investigated by
substrate zymography. Leukocyte cultures from 24-h old buffy
coats were spontaneously activated and produced high levels of
gelatinase B. Using such cultures the suppressing activity of the
Datura stramonium, Viscum album, Bauhinia purpurea, Triti-
cum aestivum and Maackia amurensis lectins on gelatinase B
induction were demonstrated. When fresh leukocyte preparations
from single blood donors were used, low levels of gelatinase B
were produced. The induction of gelatinase B was confirmed for
concanavalin A and phytohaemagglutinin (PHA-L4). In addi-
tion, the Urtica dioica, Calystegia sepium, Convolvulus arvensis
and Colchicum autumnale lectins were documented as novel and
potent inducers of gelatinase B. Since high circulating gelatinase
B levels are associated with specific pathologies, including shock
syndromes, the acute toxicity of many lectins might be partially
mediated or influenced by gelatinase induction.
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1. Introduction
Many plant lectins become increasingly well understood in
terms of molecular structure, physiological role and biological
e¡ects on mammalian cells. Since various types of plant lec-
tins are potent toxins, data on lethality in mammalian hosts
and some immunological e¡ects have been documented [1^3].
Perhaps the best studied immunological aspect is the cell ag-
glutinating property of many plant lectins. Agglutination of
white blood cells and haemagglutinating activity have often
been used as a read-out system during lectin puri¢cation pro-
cedures. Intrinsically connected with leukocyte agglutination
is the mitogenic activity of particular plant lectins [4^7]. Due
to the multivalent carbohydrate recognition, various lectins
can cross-link cells and cell receptors and abolish mitotic qui-
escence which eventually results in the transformation of, for
instance, lymphocytes into lymphoblasts [5]. The exact mech-
anism of this mitogenic signal is not known, but there exist a
number of similarities with superantigen-mediated triggering
of lymphocytes [4,5]. In brief, several lectins induce polyclonal
activation of lymphocytes which results in proliferation and
di¡erentiation into cytokine-producing cells. For example, it
has been documented that concanavalin A (Con A) and phy-
tohaemagglutinin induce the cytokines IL-1, IL-6 and the
chemotactic factor IL-8 and various other chemokines [8^10].
These two lectins thus possess various immunomodulating
e¡ects.
Leukocytes use various biochemical mechanisms to achieve
their chemotactic movement towards the in£ammatory focus.
One important mechanism is the production of extracellular
matrix metalloproteinases such as gelatinase A and gelatinase
B [11]. These enzymes enable the producer cells to degrade the
subendothelial and subepithelial basal membranes as well as
the denatured collagens in connective tissues (after cleavage
by collagenases). Gelatinase A (MMP-2) and gelatinase B
(MMP-9) are constitutive and inducible enzymes, respectively,
in in£ammatory processes [12]. In humans, the former has a
molecular mass of 65^75 kDa and is omnipresent in body
£uids and secreted by most cell types. Regulation of gelatinase
A production has been documented in specialized tissues such
as the testis and the kidney [13,14]. The inducible gelatinase B
has, depending on the species, on the producer cell type and
the posttranslational processing, a molecular mass of 85^110
kDa. This enzyme activity increases in various autoimmune
diseases such as rheumatoid arthritis and multiple sclerosis
and has recently attracted a lot of attention as a possible
target for the treatment of these diseases [15,16]. For gelati-
nase A, there is evidence that lectins can induce the activation
of the zymogen form into the active enzyme form [13]. For
gelatinase B there is limited information about induction of de
novo synthesis or activation by lectins. As a ¢rst step to in-
vestigate the possible role of lectins as environmental factors
in pathology, we have studied the regulation of gelatinases in
human leukocytes. For this purpose a unique and broad panel
of well characterized and novel plant lectins were compared
for enzyme regulation.
2. Materials and methods
2.1. Cell puri¢cation and induction
Fresh or overnight stored heparinized bu¡y coats were obtained
from the Red Cross Transfusion Centre of Antwerp, Belgium. Leu-
kocytes were fractionated by gradient centrifugation (400Ug, 30 min)
on Lymphoprep (Nycomed, Life Technologies) and the mononuclear
cell fraction (90% purity) was seeded at 5U106 cells/ml. In a further
step monocytes were isolated either by adherence (1 h, at 37‡C and
followed by two washes with serum-free medium) or by positive se-
lection with anti-CD14. The latter puri¢cation procedure was by in-
cubation (30 min at 4‡C) with paramagnetic microbeads conjugated
with a monoclonal antibody against CD14 and cell isolation using the
VarioMACS system (Miltenyl Biotec, Bergisch, Germany). Cell purity
was analysed by FACS and reached at least 80% for the anti-CD14
sorted cells. Inductions were done in 24-well plates using serum-free
cell culture medium (1 ml/well) to which the lectins were added in
concentrations ranging from 10 ng/ml to 100 Wg/ml. After incubation
at 37‡C for various time intervals, the cell culture supernatants were
collected and usually 10^20-Wl samples were su⁄cient for zymography
or cytokine analysis.
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2.2. Lectins
The following lectins [2] were used in this study (the international
nomenclature for abbreviations is used throughout): Bauhinia purpu-
rea lectin (BPA), soybean (Glycine max) agglutinin (SBA), Wisteria
£oribunda agglutinin (WFA), Dolichos bi£orus agglutinin (DBA), Da-
tura stramonium lectin (DSA), Urtica dioica agglutinin (UDA), Ama-
ranthus caudatus lectin (ACA), wheat germ (Triticum aestivum) agglu-
tinin (WGA), Maackia amurensis agglutinin (MAA), Viscum album
chitin-binding agglutinin (VisAlbCBA), pea (Pisum sativum) lectin
(PSA), Vicia faba lectin (VFL), Rhizoctonia solani agglutinin (RSA),
Colchicum autumnale agglutinin (CAA), Tulipa lectin (TxLC-I), Pha-
seolus vulgaris agglutinin E (PHA-E4), Phaseolus vulgaris agglutinin L
(PHA-L4), Allium sativum agglutinin (ASA), Allium ursinum aggluti-
nin (AUA), Galanthus nivalis agglutinin (GNA), Narcissus pseudonar-
cissus agglutinin (NPA), Hippeastrum hybrid agglutinin (HHA), Xan-
thosoma sagittifolium agglutinin (XSA), Listera ovata agglutinin
(LOA), Calystegia sepium agglutinin (Calsepa), Convolvulus arvensis
agglutinin (Conarva), Helianthus tuberosus agglutinin (Heltuba). All
lectins were electrophoretically pure [2,3,17^19] and prepared as a
stock solution of 1 mg/ml. Ten-fold dilution series were made in
0.9% pyrogen-free NaCl solution. Con A was purchased from Calbio-
chem.
2.3. Zymography
Gelatin zymography was done as previously detailed [20]. Brie£y,
for molecular weight standardization commercially available protein
standard mixtures were included (Bio-Rad, SDS-PAGE standard) and
for the identi¢cation of gelatinases A and B a laboratory control of
recombinant mouse gelatinase B, expressed in Pichia pastoris was used
[21]. After development of the enzymatic activity, scanning densitom-
etry was used to quantify the gelatinolytic activity. Signi¢cant induc-
tion or inhibition of gelatinase B was evidenced in at least two in-
dependent induction experiments.
3. Results
3.1. Gelatinase B inhibition by lectins in mononuclear cells
In a number of experiments leukocytes were prepared after
overnight storage either from pooled or individual human
bu¡y coats. It was a constant ¢nding, as measured in more
than 50 di¡erent cell isolations, that these pooled or aged
culture £uids contained gelatinase B. When such leukocyte
cultures were used, induction with lectins did not enhance
the production of gelatinase B activity (Fig. 1 and data not
shown). However, such cell cultures with high background
levels were useful to show on zymography analysis the dom-
inant presence of gelatinase B over gelatinase A and its het-
erogeneity. In some instances the zymography showed the
92.2-kDa monomer, the 110-kDa heterodimer of gelatinase
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Fig. 1. Spontaneous gelatinase production in aged bu¡y coats.
Mononuclear cells, prepared from 24 h old blood collections were
seeded at 3U106 cells in 4 ml culture medium with 2% fetal bovine
serum and stimulated for 24 h with various lectins. The lanes con-
tain 20-Wl samples stimulated with CAA, DSA, UDA, ACA, Calse-
pa, NPA, VisAlCBA, VFL, LOA and XSA, respectively. The sam-
ples in lanes 1, 2, 3 and 4 were induced with the individual lectins
at 100, 10, 1 and 0.1 Wg/ml, respectively. The lanes M contain mo-
lecular weight markers which are indicated in kDa. At the left side
gelatinase A (GA), gelatinase B (GB), the heterodimer with neutro-
phil gelatinase B-associated lipocalin (HE) and the gelatinase B ho-
modimer (HO) are indicated by small arrows. When the cells are
cultured under serum-free conditions, gelatinase A is not detectable.
Control cell cultures treated with medium only yielded similar zy-
mography pictures.
Fig. 2. Inhibition of gelatinase B production in fresh leukocytes.
Mononuclear cells were induced under serum-free conditions. All
the lanes contain 20-Wl samples induced with, respectively, VFL,
VisAlbCBA, NPA, Calsepa, ACA, UDA, DSA, CAA, WGA,
MAA, PHA-E4, SBA, Heltuba, BPA, PSA, ASA, TxLC-I, GNA,
HHA, DBA, AUA and RSA. The cultures in lanes 1, 2, 3, 4 and
5 were treated with 100 (for HHA: 81.6 Wg/ml), 10, 1, 0.1 and
0.01 Wg/ml, respectively. Lanes C1 to C6 contain control samples
from unstimulated cells, whereas the lanes M show the molecular
weight markers in kDa. At the left side, gelatinase B (GB) and its
homodimer (HO) are indicated.
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B with neutrophil gelatinase B-associated lipocalin and a 200-
kDa homodimer [22]. The inhibition of gelatinase B produc-
tion by lectins can be shown by these preparations although
the inhibitory e¡ect is more pronounced when fresh leukocyte
preparations were used. For instance, in Fig. 1 Viscum album
agglutinin (VisAlbCBA) reduced the levels of gelatinase B
monomer and dimer, whereas Datura stramonium lectin
(DSA) inhibited the levels of the gelatinase B monomers.
The latter two lectins also inhibited gelatinase B release
from fresh mononuclear cells (Fig. 2). In addition, Fig. 2
shows that Maackia amurensis (MAA), wheat germ agglutinin
(WGA) and Bauhinia purpurea (BPA) lectins inhibited signi¢-
cantly gelatinase B induction. In some instances, induction or
activation to lower molecular weight forms was observed. For
instance, tulip lectin (TxLC-I) dose-dependently induced syn-
thesis or activation of gelatinase B (Fig. 2).
3.2. Gelatinase B induction by lectins in mononuclear cells
To visualize gelatinase B induction it was essential to reduce
background levels of the enzyme in the unstimulated cultures.
This was achieved by using lower cell numbers from fresh cell
cultures under serum-free conditions. Serum, however, con-
tains the constitutive enzyme gelatinase A and might be a
helpful marker to standardize inducibility of gelatinase B.
Under serum-free cell culture conditions, the constitutive pro-
duction of the gelatinase A marker enzyme depended on the
cell type used. Fibroblasts, monocytes and granulocytes pro-
duce low, very low and no gelatinase A, respectively (data not
shown and [12]). Furthermore, it was essential that the human
leukocytes were freshly isolated, immediately puri¢ed and in-
duced. Fig. 3 illustrates the inducibility of gelatinase B by
various lectins on mononuclear leukocytes. The lectins from
Convolvulus arvensis (Conarva), Calystegia sepium (Calsepa),
Urtica dioica (UDA), Colchicum autumnale (CAA), Con A
and phytohaemagglutinin from Phaseolus vulgaris (PHA-L4)
induced gelatinase B in mononuclear leukocytes. However,
under these particular experimental conditions tulip lectin
(TxLC-I) failed to induce gelatinase B.
4. Discussion
The aim of the present study was to document whether and
which lectins alter the expression of gelatinases in human
leukocytes. Classical activation mechanisms for cytokine and
enzyme production by lymphocytes and monocytes include
cytokines and direct cell^cell contacts [9,11,20,23,24]. Lectins
have also been described as potent immunomodulators by
inducing lymphocyte activation and cytokine production
[4,5]. The secretion of metalloproteinases by lymphocytes
and monocytes has been documented for a restricted number
of lectins [12,23,25]. Gelatinase B has recently gained atten-
tion as a possible target in autoimmune diseases, such as
rheumatoid arthritis and multiple sclerosis [15]. Many auto-
immune disorders are classi¢ed as multifactorial diseases since
no single etiological agent has yet been detected and because
both genetic (e.g. human leukocyte antigens, HLA) and envi-
ronmental factors might contribute to these disease states. So
far, mainly microbial agents have been studied as environ-
mental factors, though dietary factors may be relevant too.
It is possible that vitamins [26,27] or for instance lectins,
which are often stable and protease-resistant dietary proteins,
might contribute to disease promotion by regulation of the
protease load [15]. The presence of lectin-speci¢c antibodies
in serum illustrates that lectins and/or lectin peptides are ab-
sorbed by the host. Whether such intestinal absorption can
lead to pharmacological levels, as in the present study, re-
mains, however, to be shown.
Two observations are here documented. A number of lec-
tins induce gelatinase B, whereas others seem to decrease the
induced production of gelatinase. The reasons for high gela-
tinase B activity in cell preparations of pooled bu¡y coats and
24-h aged cultures from single donors are trivial. It is known,
indeed, that direct cell^cell contacts, such as those occurring
in mixed leukocyte reactions, and small amounts of contam-
inating endotoxin, present in many serum preparations, in-
duce the production of gelatinase B [20,23,25]. Therefore, low-
er cell numbers and serum-free conditions were used. Serum,
however, contains the constitutive enzyme gelatinase A which
is a helpful marker to standardize inducibility of gelatinase B.
Under serum-free cell culture conditions, the constitutive pro-
duction of the gelatinase A marker enzyme depended on the
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Fig. 3. Induction of gelatinase B production in fresh bu¡y coats.
Mononuclear cells from a fresh bu¡y coat were isolated and seeded
at 5U104 cells per ml. After 44 h supernatants were collected and
20-Wl samples analysed by zymography. Lanes C1^3 contain samples
from control cells. The samples in the other lanes were induced
with, respectively, Conarva, Con A, Calsepa, Heltuba, UDA, CAA,
TxLC-I and PHA-L4. Lanes 1, 2 and 3 show inductions with the
lectins at 100 (for L4: 50 Wg/ml), 1 and 0.01 Wg/ml, respectively. In
lanes M the molecular weight markers are indicated in kDa. The ar-
rows GA and GB indicate the migration of gelatinases A and B, re-
spectively.
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cell type used. Fibroblasts, monocytes and granulocytes pro-
duce low, very low and no gelatinase A, respectively (data not
shown and [12]). Furthermore, it was essential that the human
leukocytes were freshly isolated, immediately puri¢ed and in-
duced. Since on zymography analysis the ‘spontaneously’ in-
duced gelatinase B in some experiments is clearly of neutro-
philic origin ([22] and Fig. 1), we postulate that the used
gelatinase B inhibitory lectins may primarily act on the secre-
tion instead of on the de novo synthesis by neutrophilic gran-
ulocytes. Granulocytes contain considerable amounts of gela-
tinase B, prepacked in speci¢c granules and ready for
immediate secretion. The lectins which inhibited neutrophil
gelatinase B secretion also inhibited gelatinase B production
in mononuclear cell preparations. According to the results
shown in Fig. 2 the inhibition of gelatinase B activity is not
exclusively determined by the nominal carbohydrate-binding
speci¢city of the lectins. Most but not all chitin-binding lectins
are inhibitory (VisAlbCBA, DSA and WGA vs. UDA). Sim-
ilarly, of all GalNAc-speci¢c lectins tested only BPA exhibited
an inhibitory activity. Finally, the Neu5AK(2,3)GalNAc-spe-
ci¢c MAA also clearly inhibited the gelatinase B activity.
Urtica dioica and Colchicum autumnale lectins, as well as
Calystegia sepium and Convolvulus arvensis lectins are docu-
mented as novel potent gelatinase B-inducing lectins. With the
latter lectins, comparable or even higher induction levels were
observed than those obtained with Con A and phytohaemag-
glutinin. The demonstration of the gelatinase B-inducing ac-
tivity of UDA, CAA, Calsepa and Conarva clearly illustrates
that lectins with a di¡erent carbohydrate-binding speci¢city
are capable of enhancing signal transduction pathways lead-
ing to the same enzyme activity in human lymphocytes. In
addition, the fact that not all lectins with the same nominal
speci¢city induce gelatinase B (e.g. UDA vs. VisAlbCBA,
DSA and WGA) suggests that the receptor glycans have a
highly speci¢c and complex structure.
Recently, we illustrated the induction of gelatinase B in
septicaemia and speculated that endotoxin-induced release of
gelatinase B in the systemic circulation might constitute a
mechanism contributing to the development of shock syn-
dromes [28]. Since some lectins induce similar levels of gelat-
inase B release from blood cells as those obtained by LPS, the
acute toxicity of these lectins might be partially caused by
such a mechanism.
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